Will Healy

Will Healy

InvestorPlace Contributor

Will Healy is a freelance financial writer. He had a lifelong interest in the stock market, trading equities since the dot-com boom. Will pursued his passion for writing after working in the corporate world as both an analyst and an insurance sales professional. He likes to approach the market by focusing on deep value, dividends, and speculation.

Will’s writing has focused on stock analysis, as well as real estate, insurance, personal finance, macroeconomics, and politics. Along with InvestorPlace, his work has appeared on numerous sites, including Seeking Alpha, Yahoo! Finance, MSN Money, Kiplinger Tax Letter, and GOBankingRates. He holds both a B.S. in Journalism and an MBA in finance and strategy.

Recent Articles

Avoid Treating Biogen Like a Speculative Drug Stock

By Will Healy, InvestorPlace Contributor

BIIB stock rose and then fell following a successful Phase 2 trial, but success in getting drugs to market will determine the performance of Biogen stock in the end.

Avoid Gildan Stock – Despite Its Post-Earnings Surge

By Will Healy, InvestorPlace Contributor

GIL stock surged higher following an earnings beat, but the lack of a moat and a steady, but average performance leaves little reason to buy GIL stock.

4 High-Growth Solar Stocks Investors Should Watch

By Will Healy, InvestorPlace Contributor

These four solar stocks offer investors high growth and low multiples. Here's what you need to know about each.

Proposed Takeover Will Overshadow Forest City Earnings

By Will Healy, InvestorPlace Contributor

As Forest City goes into earnings, the proposed takeover by Brookfield and the corresponding legal challenges will overshadow the report. Here's what FCE.A stock investors should expect.

Why There’s Still Plenty of Hope for Lumber Liquidators Stock

By Will Healy, InvestorPlace Contributor

LL stock saw a massive drop on higher revenues and lower earnings, but Lumber Liquidators remains on track for high growth.

Load More